-
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Given Average Recommendation of "Buy" by Brokerages
Source: Buzz FX / 28 Nov 2024 03:51:10 America/New_York
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Given Average Recommendation of "Buy" by Brokerages Written by MarketBeat November 28, 2024 Share Link copied to clipboard. Shares of Cullinan Therapeutics, Inc.
Read more...